XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net income $ 354,200,000 $ 381,400,000
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Gain on sale of business 0 (4,000,000.0)
Asset impairments 700,000 0
Depreciation 56,500,000 49,900,000
Amortization of intangible assets 96,500,000 75,000,000.0
Share-based compensation expense 23,700,000 20,900,000
Deferred income taxes (1,000,000.0) 400,000
Changes in (net of the effect from acquisitions/divestitures and foreign currency translation):    
Receivables – net (20,200,000) (14,500,000)
Inventories – net (49,400,000) (21,600,000)
Other current assets (1,400,000) (4,600,000)
Trade accounts payable (1,100,000) 15,300,000
Deferred revenue (1,100,000) (4,300,000)
Accrued expenses 10,400,000 (500,000)
Other – net 3,100,000 2,100,000
Net cash flows provided by operating activities 470,900,000 495,500,000
Cash flows from investing activities    
Capital expenditures (43,900,000) (49,600,000)
Acquisition of business, net of cash acquired (76,500,000) (984,500,000)
Proceeds from sale of business, net of cash remitted 0 45,100,000
Other – net 400,000 (2,800,000)
Net cash flows used in investing activities (120,000,000.0) (991,800,000)
Cash flows from financing activities    
Borrowings under revolving credit facilities 197,000,000.0 279,300,000
Proceeds from issuance of long-term borrowings 0 496,700,000
Payment of long-term borrowings (100,000,000.0) (25,000,000.0)
Payments under revolving credit facilities (185,800,000) 0
Debt issuance costs 0 (1,200,000)
Cash dividends paid to shareholders (159,400,000) (153,000,000.0)
(Payments) proceeds from share issuances, net of shares withheld for taxes (1,200,000) 10,500,000
Repurchases of common stock (175,000,000.0) 0
Other – net (500,000) (600,000)
Net cash flows (used in) provided by financing activities (424,900,000) 606,700,000
Effect of exchange rate changes on cash and cash equivalents 34,800,000 6,600,000
Net (decrease) increase in cash and cash equivalents and restricted cash (39,200,000) 117,000,000.0
Cash and cash equivalents and restricted cash at beginning of year [1] 638,900,000 534,300,000
Cash and cash equivalents and restricted cash at end of period [1] 599,700,000 651,300,000
Cash paid for:    
Interest 52,100,000 25,500,000
Income taxes – net $ 103,300,000 $ 120,200,000
[1] Includes $5.9 million of restricted cash at September 30, 2025 and $18.1 million at both September 30, 2024 and December 31, 2024. At September 30, 2025, $3.0 million of the restricted cash has been included in Other current assets and $2.9 million has been included in Other noncurrent assets in the Condensed Consolidated Balance Sheets. At September 30, 2024 and December 31, 2024, $18.1 million was included in Other current assets in the Condensed Consolidated Balance Sheets. There was no restricted cash as of December 31, 2023.